Free shipping for all orders over $75


With the rise of COVID-19 since the start of 2020, so many people, business, and industries have been affected. Through all this, research has begun in studying CBD’s effects to combat COVID. Researchers at the University of Maryland School of Medicine have begun to dwell in to the depths of CBD and its possible anti-viral effects on COVID infected cells.

Taken from   – Reporter, Baltimore Business Journal

Ciaran Skerry, an assistant professor of microbiology and immunology at UMB, is leading a newly launched lab-based study to investigate whether cannabidiol (CBD), an ingredient of cannabis, has anti-viral effects on cells infected with Covid-19. The researchers will use a proprietary CBD formula produced by Baltimore-based firm bioRemedies MD to examine interactions between CBD and the respiratory disease, and determine whether CBD may be used as an effective treatment.

CBD is derived from the hemp plant, a kind of cannabis which unlike marijuana does not have the psychoactive effects produced by high THC levels. Hemp has grown in popularity among farmers and health and wellness retailers in recent years. Its ingredients, including CBD, can be used in a variety of consumer products, including cosmetics, biofuel and food. CBD is purported to have various health benefits, including the reduction of depression and anxiety, but scientific research validating such benefits has been limited to this point.

Dr. John Dombrowski of bioRemedies MD said it is “essential” for CBD companies like his to contribute to pre-clinical and clinical research.

“CBD will not be recognized as a therapeutic treatment for diseases and conditions without performing the critical research,” Dombrowski said in a statement.

Skerry’s team will primarily be studying CBD’s potential usefulness as an anti-inflammatory agent. Covid-19 causes aggressive inflammatory responses in infected patients, causing damage to the airways and potentially leading to acute respiratory distress or respiratory failure. Respiratory failure is the reported cause of death in approximately 70% of Covid-19 fatalities. Skerry’s previous research work has shown that CBD had certain anti-inflammatory effects against bacterial infections.

The Maryland-based study will attempt to further determine if CBD can reduce the activity of ACE2, and also if CBD could be used to help “protect against the excessive inflammatory responses to the virus associated with lung damage and death,” Skerry said in a statement.

Patrick Kelly, managing member for bioRemedies MD, said the Baltimore company is proud to partner with UMB’s School of Medicine on this new research effort.

“As I like to say, it’s ‘all hands on deck’, for every facet of science to defend individuals during this pandemic. We are truly all in this together,” he said in a statement.

(Source: )

It’ll be interesting where these studies bring CBD in the eyes of the public and medicinal practitioners alike. Stay in touch for more updates as we will be keeping an eye and open mind on this topic for the indefinite future of this epidemic.

PURE Hemp Supply, Paving a way to a Purer Lifestyle